Abstract
The existing methods of biofabrication for vascular tissue engineering are still bioreactor-based, extremely expensive, laborious and time consuming and, furthermore, not automated, which would be essential for an economically successful large-scale commercialization. The advances in nanotechnology can bring additional functionality to vascular scaffolds, optimize internal vascular graft surface and even help to direct the differentiation of stem cells into the vascular cell phenotype. The development of rapid nanotechnology-based methods of vascular tissue biofabrication represents one of most important recent technological breakthroughs in vascular tissue engineering because it dramatically accelerates vascular tissue assembly and, importantly, also eliminates the need for a bioreactor-based scaffold cellularization process.
| Original language | English |
|---|---|
| Pages (from-to) | 338-344 |
| Number of pages | 7 |
| Journal | Trends in Biotechnology |
| Volume | 26 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jun 2008 |
| Externally published | Yes |
Field of Science*
- 2.6 Medical engineering
- 2.5 Materials engineering
- 3.4 Medical biotechnology
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database